Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
143B |
Human osteosarcoma cell line | ATCC CRL-8303 | Human | bone | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. D’Angelo, Dissertation, University of Parma | Link | |
293L |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | bacmid | stable transfection | Metafectene PRO | publication | P. Dabral et al., J. of Virology, 2019, 93: e02256-18, doi.org/10.1128/JVI.02256-18 | Link | ||
293L |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | bacmid | stable transfection | Metafectene PRO | publication | M. E. McDowell, Dissertation, 2012, University of Nevada | Link | ||
293L |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | bacmid | stable transfection | Metafectene PRO | publication | T. Uppal et al., J. of Virology, 2019, 93, 8 e01983-18, doi.org/10.1128/JVI.01983-18 | Link | ||
293L |
Human embryonic kidney cell line (derivat of HEK293) | Human | urinary system | cell line | adherent | bacmid | stable transfection | Metafectene PRO | publication | P. Dabral, Dissertation, 2019, University of Nevada | Link | ||
2D8 |
chicken B cell line, reticuloendotheliosis virus transformed | Chicken | immune system | cell line | plasmid | stable transfection | Metafectene PRO | publication | V. Turowski et al., PLOSONE, DOI:10.1371/journal.pone.0151513 | Link | |||
A-2780 |
Human ovarian carcinoma cell line | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | C.F.T. Taute, PhD Thesis, 2013, University of the Western Cape | Link | ||
AGS |
Human gastric adenocarcinoma cell line | ATCC CRL-1739 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | H. Jee, Dissertation, 2013, Seoul National University | Link | |
C-1300 |
Mouse neuroblastoma cell line | Mouse | brain | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. Stermann, Dissertation, 2014, Humboldt-Universitaet zu Berlin | Link | ||
C4-2 |
Human prostate carcinoma cell line (derivative of LNCaP) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | R.C. Peery, Dissertation,, 2020, Indiana University | Link | ||
CM7/1 |
Mouse embryonic stem cell line | Mouse | unknown | stem cell | adherent | plasmid | stable transfection | Metafectene PRO | publication | D. Weber, Doctoral Thesis, 2014, Julius-Maximilians-Universitaet Wuerzburg | Link | ||
Flp-In T-REx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., J. Cell Biol., 2021, 220, 6, doi.org/10.1083/jcb.202006128 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
Flp-in TREx 293 |
Human embryonic kidney cell line (derivative of HEK293) | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | B.K. Shrestha et al., J Biol Chem., 2020, 295(5): 1240–1260, doi: 10.1074/jbc.RA119.010068 | Link | ||
Flp-In TREx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | N.E. Taboko, Masters Thesis, 2020, UiT Norges arktiske universitet | Link | ||
Flp-In TREx HeLa |
Human cervix adenocarcinoma cell line (derivative of HeLa) | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | T. M. Nthiga et al., The EMBO J., 39: e103649, DOI 10.15252/embj.2019103649 | Link | ||
G3K |
Human pancreas carcinoma cell line (derivat of MIA PaCa-2) | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | |||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | M. Arechederra et al., J. Biol. Chem., Feb 2015; 290: 4383 - 4397 | ||
HCT116 |
Human colon adenocarcinoma cell line | ATCC CCL-247 | Human | digestive organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | U. Stein et al., 2014, US 2014/0294957 (Patent) | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | S. Pankiv et al., J. Cell Biol., Jan 2010; 188: 253 - 269 | Link | |
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | A. Pálvölgyi et al., Cellular Signalling, 2018, doi:10.1016/j.cellsig.2018.08.010 | ||
HEK293 |
Human embryonic kidney cell line | ATCC CRL-1573 | Human | urinary system | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | R. Martínez-Mármol, Scientific Reports, 7:42395, DOI: 10.1038/srep42395 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | Y. P. Abudu et al., J. Cell Biol., 2021, 220(8): e202009092, doi: 10.1083/jcb.202009092 | Link | |
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | plasmid | stable transfection | Metafectene PRO | publication | R. Martınez-Marmol et al., Cell. Mol. Life Sci., 2016, 73:1515-1528; DOI 10.1007/s00018-015-2082-0 | |||
HeLa |
Human cervix adenocarcinoma cell line | ATCC CCL-2 | Human | genital tract | cell line | adherent | bacmid | stable transfection | Metafectene PRO | publication | C. Heissenberger et al., Nucleic Acids Res., 2019, 47, 22: 11807–11825, doi: 10.1093/nar/gkz1043 | Link |